Comprehensive Healthcare Systems Inc
CHS
Water Ways Technologies Inc
WWT
TVI Pacific Inc
TVI
Magna Terra Minerals Inc
MTT
Marksmen Energy Inc
MAH
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 22.00%-571.99K | -171.70%-2.02M | -40.34%-522.02K | 80.25%-203.54K | -113.31%-565.6K | -2,891.90%-733.34K | 672.00%2.82M | -114.90%-371.95K | -78.55%-1.03M | 383.75%4.25M |
Net income from continuing operations | 14.15%-768.05K | 53.91%-3.2M | 87.63%-875.84K | -43.57%-707.69K | -119.85%-717.35K | -192.70%-894.67K | -1,388.27%-6.93M | -516.55%-7.08M | 27.57%-492.91K | 60.77%-326.29K |
Operating gains losses | ---- | --199.52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -64.83%117.74K | -72.08%1.12M | -87.76%292.74K | 74.55%274.74K | -71.07%222.74K | -52.93%334.74K | 818.85%4.03M | 445.20%2.39M | --157.4K | --770K |
Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --4.23M | ---- | ---- | ---- |
Remuneration paid in stock | 167.30%193.87K | -60.08%184.28K | -60.62%36.9K | -61.37%37.43K | -61.37%37.43K | -58.35%72.53K | -63.04%461.63K | -85.93%93.69K | 14.52%96.89K | 14.52%96.89K |
Other non cashItems | 9.25%9.91K | 12.19%39.64K | -14.17%8.15K | 31.53%11.73K | 12.42%10.69K | 22.38%9.07K | -49.27%35.34K | 9.31%9.5K | 2,356.75%8.92K | -88.00%9.51K |
Change In working capital | 50.80%-125.46K | -137.73%-377.33K | -970.12%-183.48K | 122.51%180.26K | -103.22%-119.1K | 86.45%-255.01K | 156.04%1M | 94.57%-17.15K | -4,434.53%-800.67K | 545.77%3.7M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 22.00%-571.99K | -171.70%-2.02M | -40.34%-522.02K | 80.25%-203.54K | -113.31%-565.6K | -2,891.90%-733.34K | 672.00%2.82M | -114.90%-371.95K | -78.55%-1.03M | 383.75%4.25M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 85.06%-97.21K | 97.92%-252.47K | 116.27%337.73K | 117.78%197.93K | 98.23%-137.32K | 46.43%-650.82K | -85.61%-12.15M | 15.25%-2.08M | 64.68%-1.11M | -3,119.04%-7.75M |
Capital expenditure reported | 69.99%-19.9K | 93.08%-294.23K | -210.28%-135.58K | 94.78%-51.05K | ---41.3K | ---66.29K | ---4.25M | --122.95K | ---978.59K | ---- |
Net PPE purchase and sale | 0.00%-23.74K | --215.25K | ---- | ---- | ---- | 97.14%-23.74K | --0 | ---- | ---- | ---- |
Net investment purchase and sale | -195.31%-25.36K | 40.66%-66.15K | -105.38%-5.3K | 41.55%-47.4K | ---4.86K | ---8.59K | 56.31%-111.47K | ---2.58K | ---81.09K | ---- |
Net other investing changes | 94.89%-28.22K | 98.62%-107.35K | 111.99%263.36K | 652.77%296.38K | 97.87%-114.89K | -99.09%-552.2K | -107.99%-7.78M | -33.02%-2.2M | 95.33%-53.62K | -2,136.35%-5.38M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 85.06%-97.21K | 97.92%-252.47K | 116.27%337.73K | 117.78%197.93K | 98.23%-137.32K | 46.43%-650.82K | -85.61%-12.15M | 15.25%-2.08M | 64.68%-1.11M | -3,119.04%-7.75M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -49.64%672.24K | -42.71%2.27M | -79.33%193.86K | -93.55%90.63K | 650K | -17.49%1.34M | 94.54%3.96M | -47.81%937.81K | 1.41M | 0 |
Net issuance payments of debt | ---- | -171.87%-94.94K | ---- | ---- | ---- | ---- | 94.23%-34.92K | ---- | ---- | ---- |
Net common stock issuance | --890.85K | -1.00%2.42M | ---- | ---- | ---- | --0 | 1,980.18%2.44M | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | ---- | ---- | -40.89%1.64M | -99.28%20.04K | --0 | --0 |
Net other financing activities | -116.38%-218.61K | 36.63%-53.37K | -42.94%-2.13M | -93.55%90.63K | --650K | --1.34M | ---84.23K | ---1.49M | --1.41M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -49.64%672.24K | -42.71%2.27M | -79.33%193.86K | -93.55%90.63K | --650K | -17.49%1.34M | 94.54%3.96M | -47.81%937.81K | --1.41M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -4.53%157.79K | -97.01%165.27K | -91.15%148.22K | -97.38%63.2K | -98.04%116.12K | -97.01%165.27K | -47.50%5.53M | -54.56%1.67M | -67.45%2.41M | -35.44%5.91M |
Current changes in cash | 106.20%3.05K | 99.86%-7.49K | 100.63%9.57K | 111.51%85.02K | 98.49%-52.92K | -112.98%-49.16K | -7.23%-5.37M | -181.80%-1.51M | 80.20%-738.45K | -101.08%-3.5M |
End cash Position | 38.51%160.83K | -4.53%157.79K | -4.53%157.79K | -91.15%148.22K | -97.38%63.2K | -98.04%116.12K | -97.01%165.27K | -97.01%165.27K | -54.56%1.67M | -67.45%2.41M |
Free cash from | 25.23%-615.62K | -62.08%-2.32M | -164.09%-657.6K | 87.33%-254.59K | -130.88%-583.17K | 3.77%-823.37K | 52.97%-1.43M | -112.74%-249.01K | 22.20%-2.01M | 226.05%1.89M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.